Picture of Onriva plus BexiCapsule
Picture of Onriva plus BexiCapsule

Onriva plus BexiCapsule

Category: Pharmacy
SKU: BEP_950773
Seller: Best Buy Pharma
Tk 70
0 review(s)

Call For Order : 09613-800800

Medicine Overview of Onriva Plus Bexicap 50mcg+110mcg Capsule

Introduction
Onriva Plus Bexicap is used for the treatment of chronic obstructive pulmonary disorder (a lung disorder in which the flow of air to the lungs is blocked). It helps in relaxing the muscles of the air passages and making it easier to breathe. It relieves coughing, wheezing and feeling short of breath. Your doctor will tell you how often you need to use your inhaler. The effect of this medicine may be noticeable after a few days but will only reach its maximum after a few weeks. This medicine must be used regularly to be effective, so go on taking...
...
Uses of Onriva Plus Bexicap
  • Chronic obstructive pulmonary disease (COPD)
Side effects of Onriva Plus Bexicap
Common
  • Indigestion
  • High blood pressure
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Chest pain
  • Fever
  • Urinary retention
  • Sore throat
  • Cough
  • Headache
  • Dizziness
  • Allergic reaction
  • Increased glucose level in blood
  • Inflammation of the nose
  • Sinus inflammation
  • Urinary tract infection
How to use Onriva Plus Bexicap
Take this medicine in the dose and duration as advised by your doctor. Check the label before use.
How Onriva Plus Bexicap works
Onriva Plus Bexicap is a combination of two medicines: Indacaterol and Glycopyrrolate which treat chronic obstructive pulmonary disease (COPD). Indacaterol is a bronchodilator which works by relaxing the muscles in the airways and widens the airways. Glycopyrrolate is an anticholinergic which works by decreasing the secretions in the airways. Together, they make breathing easier.
Quick Tips
  • Onriva Plus Bexicap is a combination of two medicines that makes breathing easier for patients with chronic obstructive pulmonary disease (COPD).
  • This medicine is for inhalation only. The tablet should not be swallowed.
  • It should be taken at the same time each day.
  • It does not work right away and should not be used to relieve sudden breathing problems.
  • Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
  • Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help.
  • Your doctor may regularly monitor your blood potassium levels as low oxygen levels in the blood (hypoxia) and COPD medicines such as Onriva Plus Bexicap can lower potassium levels in blood.
Brief Description
Indication
Bronchodilator treatment to relieve symptoms in patients with, chronic obstructive pulmonary disease (COPD).
Administration
For inhalation use only. The capsules must not be swallowed.
...
Adult Dose
Adult Chronic Obstructive Pulmonary Disease (COPD) Inhale 1 cap with inhaler once daily. Hepatic Impairment: This can be used at the recommended dose in patients with mild and moderate hepatic impairment. There are no data available for the use of Indacaterol + Glycopyrronium Breezhaler in patients with severe hepatic impairment, therefore caution should be observed in these patients.
...
Child Dose
Safety and efficacy not established
...
Renal Dose
Renal Impairment: This can be used at the recommended dose in patients with mild to moderate renal impairment. In patients with severe renal impairment or end-stage renal disease requiring dialysis it should be used only if the expected benefit outweighs the potential risk.
Contraindication
Hypersensitivity to indacaterol, glycopyrronium or to any of the excipients of Indacaterol + Glycopyrronium. All LABAs are contraindicated in patients with asthma without use of a long-term asthma control medication Indacaterol/glycopyrrolate is not indicated for the treatment of asthma Use in children: This should not be used in patients <18 years.
...
Mode of Action
Glycopyrronium: Long-acting muscarinic antagonist (LAMA); often referred to as an anticholinergic; produces bronchodilation by inhibiting acetylcholine’s effect on muscarinic receptors in the airway smooth muscle Indacaterol: Long-acting beta2-agonist (LABA); stimulates intracellular adenyl cyclase, causing conversion of ATP to cyclic AMP; increased cyclic AMP levels cause relaxation of bronchial smooth muscle
...
Precaution
Concomitant use w/ long-acting beta-agonists or long-acting muscarinic antagonists. Not for the treatment of asthma. Immediately discontinue use if hypersensitivity & paradoxical bronchospasm occurs. Narrow-angle glaucoma, urinary retention, CV disorders (CAD, acute MI, cardiac arrhythmia, HTN), convulsive disorders or thyrotoxicosis, severe renal impairment; hypokalaemia; hyperglycaemia. Pregnancy & lactation.
...
Side Effect
1-10% Nasopharyngitis (4.1%),Hypertension (2%),Back pain (1.8%),Oropharyngeal pain (1.6%)
...
Interaction
Decreases levodopa effects. Effects may be enhanced by using drugs with antimuscarinic properties or MAOIs concurrently. May antagonise the GI effects of cisapride, metoclopramide and dompeidone. Potentially Fatal: IV admin in the presence of cyclopropane anesth can result in ventricular arrhythmias.
...
Customer Questions and answers :

Login to ask a question